Schedule of basic and diluted net loss per share |
|
|
|
For the Year Ended December 31, 2019 |
|
|
|
Income
(Numerator)
|
|
|
Shares
(Denominator)
|
|
|
Per-Share
Amount
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
1,051,825 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic EPS |
|
|
|
|
|
|
|
|
|
|
|
|
Income available to common stockholders |
|
|
1,051,825 |
|
|
|
135,154,931 |
|
|
$ |
0.01 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of Dilutive Securities |
|
|
|
|
|
|
|
|
|
|
|
|
Unvested restricted stock |
|
|
|
|
|
|
858,856 |
|
|
|
|
|
Options |
|
|
|
|
|
|
392,784 |
|
|
|
|
|
Warrants |
|
|
|
|
|
|
447,431 |
|
|
|
|
|
Warrants – liability classified |
|
|
(9,250,612 |
) |
|
|
32,706,263 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted EPS |
|
|
|
|
|
|
|
|
|
|
|
|
Loss available to common stockholders + assumed conversions |
|
$ |
(8,198,787 |
) |
|
|
169,560,265 |
|
|
$ |
(0.05 |
) |
|
|
For the Year Ended December 31, 2018 |
|
|
|
Income
(Numerator)
|
|
|
Shares
(Denominator)
|
|
|
Per-Share
Amount
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(19,194,236 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and Diluted EPS |
|
|
|
|
|
|
|
|
|
|
|
|
Loss available to common stockholders |
|
$ |
(19,194,236 |
) |
|
|
121,154,334 |
|
|
$ |
(0.16 |
) |
|
Schedule of anti-dilutive securities |
|
|
Three Months Ended
March 31,
|
|
|
|
2020 |
|
|
2019 |
|
Stock options |
|
|
4,512,715 |
|
|
|
3,600,073 |
|
Unvested restricted stock |
|
|
643,501 |
|
|
|
1,093,501 |
|
Common shares underlying convertible debt |
|
|
5,125,363 |
|
|
|
15,000,000 |
|
Warrants |
|
|
23,593,356 |
|
|
|
58,130,750 |
|
|
|
|
Year Ended
December 31,
|
|
|
|
2019 |
|
|
2018 |
|
Stock options |
|
|
4,119,931 |
|
|
|
3,600,073 |
|
Unvested restricted stock |
|
|
234,645 |
|
|
|
1,543,501 |
|
Common shares underlying convertible debt |
|
|
5,036,250 |
|
|
|
5,000,000 |
|
Warrants |
|
|
20,712,000 |
|
|
|
53,130,750 |
|
|